Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience.

Angela RomanoValeria GuglielminoAndrea Di Paolantonio Giulia BisogniMario SabatelliGiacomo Della MarcaAngelo Maria MinnellaMartina MaceroniSimone BellaviaIrene ScalaEleonora SabatelliEleonora RolloMarco Luigetti

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)

We suggest pupillometry may play a role as a reliable and non-invasive biomarker to evaluate ATTRv disease severity and monitor its progression.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors